Trump Nominates Dr. Marty Makary as FDA Commissioner

Makary, a Johns Hopkins surgeon and public policy expert, has been critical of FDA policies and COVID-19 public health measures.

Dr. Marty Makary, known for his critiques of public health policies and vaccine mandates, has been nominated by President-elect Donald Trump to lead the FDA.
Makary has expressed concerns about the medical establishment's handling of COVID-19 and has advocated for changes in vaccine schedules, citing the need for personal choice and risk-benefit assessments.
If confirmed, Makary would oversee an FDA grappling with issues like compounded weight-loss drugs, which intersect with his role at the telehealth company Sesame.
Makary has previously criticized the FDA for slow innovation approvals, reliance on remote work, and insufficient use of advisory panels during the pandemic.
Trump also announced Robert F. Kennedy Jr. as his pick for Secretary of Health and Human Services, signaling potential shifts in public health and regulatory policies.